Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Century Therapeutics FY EPS $(2.30) Misses $(2.09) Estimate, Sales $2.23M Miss $3.82M Estimate

Author: Benzinga Newsdesk | March 14, 2024 07:36am

Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(2.30) per share which missed the analyst consensus estimate of $(2.09) by 10.05 percent. This is a 1.32 percent decrease over losses of $(2.27) per share from the same period last year. The company reported quarterly sales of $2.23 million which missed the analyst consensus estimate of $3.82 million by 41.55 percent. This is a 57.01 percent decrease over sales of $5.20 million the same period last year.

Posted In: IPSC